AlloVir, Inc. (ALVR) Financials

ALVR Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 190.8 million 45.0 million
2023-09-30 248.3 million 53.0 million
2023-06-30 282.7 million 53.6 million
2023-03-31 244.0 million 50.5 million

ALVR Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -30.7 million 10.0 million
2023-09-30 -34.5 million 10.5 million
2023-06-30 -27.1 million 10.3 million
2023-03-31 -32.1 million 10.0 million

ALVR Net Income

No data available :(

ALVR Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 183.9 million - 27.4 million
2023-09-30 213.3 million - 32.9 million
2023-06-30 246.5 million - 31.5 million
2023-03-31 202.6 million - 33.8 million

ALVR Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 114.0 million
2023-09-30 113.9 million
2023-06-30 94.6 million
2023-03-31 93.3 million

ALVR Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 - 33.2 million 10.5 million -
2023-09-30 - 34.2 million 12.8 million -
2023-06-30 - 31.3 million 16.0 million -
2023-03-31 - 30.7 million 12.5 million -

ALVR Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 - 141000
2023-09-30 - 3.6 million
2023-06-30 - -
2023-03-31 - 547000

ALVR

Price: $0.80

52 week price:
0.62
6.12

Earnings Per Share: -1.83 USD

P/E Ratio: -0.43

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Volume: 86807

Market Capitalization: 85.8 million

Links: